Patienter i Zestril behandling der udvikler gulsot eller markant stigning i leverenzymer bør seponere Zestril behandlingen og modtage passende medicinsk opfølgning.
Patients receiving Zestril who develop jaundice or marked elevations of hepatic enzymes should discontinue Zestril and receive appropriate medical follow-up.